July 15, 2025: A Big Ten CRC study, BTCRC-BRE18-337, led by Sneha Phadke, DO, MPH, of the University of Iowa Holden Comprehensive Cancer Center, was published in Breast Cancer Research and Treatment on June 5, 2025. The article is titled, “Phase I/II trial investigating gedatolisib plus talazoparib in advanced triple negative or BRCA1/2 positive, HER2 negative breast cancers.” Read More
April 25, 2025: A Big Ten CRC clinical trial, BTCRC-BRE19-409, titled, “Alpelisib (BYL719) with continued endocrine therapy following progression on endocrine therapy in hormone receptor–positive, HER2-negative, PIK3CA-mutant metastatic breast cancer,” was presented as a poster presentation at the American Association for Cancer Research® (AACR) Annual Meeting 2025 by Darian Louthan, clinical research coordinator at UW Carbone Cancer Center. Read More
July 8, 2025: The Big Ten Cancer Research Consortium is excited to announce registration is now open for the 2025 Big Ten CRC Summit on Friday, September 12, from 7:30 a.m. to 2:15 p.m. CT at the Big Ten Conference Headquarters in Rosemont, Ill. Read More
June 20, 2025: The Big Ten Cancer Research Consortium is pleased to announce John Hays, MD, PhD, as the new chair of the Steering Committee. Dr. Hays is an associate professor in the College of Medicine and member of the Translational Therapeutics Program at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. With a specialty in medical oncology, Dr. Hays brings a commitment to forward thinking and a wealth of experience as a successful leader and mentor. Read More
June 11, 2025: In this month’s Across the Consortium, the Big Ten Cancer Research Consortium spotlights a wide range of updates from our member institutions. This issue showcases groundbreaking discoveries, acts of philanthropy, and leadership that will shape not only the Big Ten Cancer Research Consortium but also the future of cancer research itself. You’ll also find news of cancer conferences, new research facilities, and impactful research advances. Read More
June 2, 2025: This month, the Big Ten CRC highlights The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) as our featured member. Asrar Alahmadi, MBBS, serves as an assistant professor in the College of Medicine at The Ohio State University. Dr. Alahmadi is a medical oncologist who specializes in treating thoracic malignancies, including non-small cell lung cancer, small cell lung cancer, thymoma, and mesothelioma. She received her medical degree from King Abdulaziz University in Jeddah, Saudi Arabia, and completed her fellowship in hematology and oncology at Case Western Reserve University in Cleveland, Ohio. Dr. Alahmadi serves as principal investigator of the OSUCCC – James-led trial representing the first... Read More
May 22, 2025: In this month’s Across the Consortium, the Big Ten Cancer Research Consortium spotlights a wide range of updates from our member institutions. This issue covers the impact of budget cuts, celebrates distinguished faculty, honors Asian American Pacific Islander Desi Heritage Month, and announces key leadership additions. You’ll also find highlights of media coverage, participation in cancer conferences and forums, recent advances in cancer research and treatment, prevention and recurrence efforts, and the unveiling of new hospital facilities. Read More
May 13, 2025: This month, the Big Ten Cancer Research Consortium highlights Michigan State University as our featured member. Daniel Isaac, DO, MS, serves as the director of clinical research at Michigan State University Division of Hematology/Oncology. Dr. Isaac joined faculty at Michigan State University in 2019. His research interests are focused on genitourinary malignancies. His current research includes investigations of novel biomarkers in prostate cancer. Dr. Isaac also currently serves on the board of the Michigan Society of Hematology Oncology and has been selected as President-elect. Dr. Isaac earned a Master of Science in Biomechanics and Mechanical Engineering, as well as a Doctor of Osteopathic Medicine from the Edward... Read More
May 12, 2025: The Big Ten Cancer Research Consortium (Big Ten CRC) is set to participate in the American Society of Clinical Oncology® (ASCO) 2025 Annual Meeting in Chicago from May 30 to June 3. During the event, two Big Ten CRC studies will be presented, working group meetings will take place, and the Big Ten CRC will host a joint reception with Hoosier Cancer Research Network (HCRN). The Big Ten CRC will also be represented in the exhibit hall at HCRN’s booth, #36117.
Study Presentations
Two Big Ten CRC studies, BTCRC-GI22-588 and BTCRC-LUN16-081, will be presented during ASCO.
BTCRC-GI22-588: A phase II...
Read More
Subscribe to the Big Ten CRC Newsletter
X
Facebook
YouTube